CLINICAL CASE

A case report of DOPA-responsive dystonia in a young woman

Belykh NA2, Akhkyamova MA2, Gusev VV1,2,3, Lvova OA2,3
About authors

1 Central Clinical Hospital № 23, Yekaterinburg, Russia

2 Ural State Medical University, Yekaterinburg, Russia

3 Yeltsin Ural Federal University, Yekaterinburg, Russia

Correspondence should be addressed: Nikita А. Belykh
Repina, 3, Yekaterinburg, 620014; moc.liamg@hkilebatikin

About paper

Compliance with ethical standards: the study was approved by the Ethics Committee of Ural State Medical University (Protocol № 1451/19 dated September 20, 2019). The patient gave informed consent to participate in the study.

Author contribution: Belykh NA analyzed the literature, made the differential diagnosis, participated in establishing the definitive diagnoses followed the patient up for 3 years. Akhkyamova MA examined the patient, collected her medical history, participated in establishing the diagnosis, followed the patient up for 3 years, wrote the manuscript. Gusev VV followed the patient up; ordered diagnostic tests, prescribed treatment and monitored its course; provided the patient’s medical history; helped with the application to the Ethics Committee. Lvova OA advised the patient on the genetic test and interpreted its results.

Received: 2020-05-14 Accepted: 2020-05-28 Published online: 2020-06-05
|
Fig. 1. Dystonia of the right foot before therapy with levodopa
Fig. 2. Brain MRI: grade I cortical atrophy, no signs of focal or diffuse cerebral pathology
Fig. 3. Cervical spine MRI: stage 1 degenerative disc disease at С3–С6, small disc osteophyte complex at С5–С6. No pathological foci detected